TD Cowen raised the firm’s price target on HCA Healthcare (HCA) to $529 from $490 and keeps a Buy rating on the shares. The firm updated its model following Q4 results where EBITDA was above consensus driven by expense controls but its growth guidance was wide but positive given cautious expectations.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $598 from $525 at UBS
- HCA Healthcare price target raised to $540 from $500 at Oppenheimer
- HCA Healthcare price target raised to $588 from $525 at Cantor Fitzgerald
- HCA Healthcare price target raised to $550 from $500 at KeyBanc
- HCA Healthcare price target raised to $551 from $494 at Barclays